These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 11716066)

  • 21. Molecular targeting for malignant gliomas (Review).
    Kondo Y; Hollingsworth EF; Kondo S
    Int J Oncol; 2004 May; 24(5):1101-9. PubMed ID: 15067331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain.
    Furnari FB; Lin H; Huang HS; Cavenee WK
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12479-84. PubMed ID: 9356475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adhesion molecules and the extracellular matrix as drug targets for glioma.
    Shimizu T; Kurozumi K; Ishida J; Ichikawa T; Date I
    Brain Tumor Pathol; 2016 Apr; 33(2):97-106. PubMed ID: 26992378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular abnormalities and correlations with tumor response and outcome in glioma patients.
    Pollack IF; Hamilton RL; Finkelstein SD; Lieberman F
    Neuroimaging Clin N Am; 2002 Nov; 12(4):627-39. PubMed ID: 12687916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling Determinants of Glioma Cell Invasion.
    Kwiatkowska A; Symons M
    Adv Exp Med Biol; 2020; 1202():129-149. PubMed ID: 32034712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenes: cause or consequence in the development of glial tumors.
    Akbasak A; Sunar-Akbasak B
    J Neurol Sci; 1992 Sep; 111(2):119-33. PubMed ID: 1331337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.
    Davies MP; Gibbs FE; Halliwell N; Joyce KA; Roebuck MM; Rossi ML; Salisbury J; Sibson DR; Tacconi L; Walker C
    Br J Cancer; 1999 Mar; 79(9-10):1542-8. PubMed ID: 10188904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ECM-mediated glioma cell invasion.
    Goldbrunner RH; Bernstein JJ; Tonn JC
    Microsc Res Tech; 1998 Nov; 43(3):250-7. PubMed ID: 9840803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain tumor cell invasion, anatomical and biological considerations.
    Thorsen F; Tysnes BB
    Anticancer Res; 1997; 17(6B):4121-6. PubMed ID: 9428345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genes implicated in glial tumors].
    Sanson M; Marie Y; Huguet S; He J; Hoang-Xuan K
    Morphologie; 2000 Jun; 84(265):51-5. PubMed ID: 11048299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.
    Peng G; Liao Y; Shen C
    Pathol Oncol Res; 2017 Apr; 23(2):369-376. PubMed ID: 27663885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
    Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T
    Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
    Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
    J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition.
    Rajesh Y; Biswas A; Mandal M
    Exp Cell Res; 2017 Oct; 359(2):299-311. PubMed ID: 28844885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrins: molecular determinants of glioma invasion.
    D'Abaco GM; Kaye AH
    J Clin Neurosci; 2007 Nov; 14(11):1041-8. PubMed ID: 17954373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of brain neoplasms.
    Shapiro JR
    Curr Neurol Neurosci Rep; 2001 May; 1(3):217-24. PubMed ID: 11898521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN.
    Koul D; Parthasarathy R; Shen R; Davies MA; Jasser SA; Chintala SK; Rao JS; Sun Y; Benvenisite EN; Liu TJ; Yung WK
    Oncogene; 2001 Oct; 20(46):6669-78. PubMed ID: 11709701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
    Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
    Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.